@article{fc3da31ad36148b3afc1b8a45540eeea,
title = "Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer",
keywords = "Durvalumab, Endometrial cancer, Lay summary, Olaparib, Plain language summary",
author = "\{DUO-E Investigators\} and Westin, \{Shannon N.\} and Kathleen Moore and Chon, \{Hye Sook\} and Lee, \{Jung Yun\} and \{Thomes Pepin\}, Jessica and Michael Sundborg and Ayelet Shai and \{de la Garza\}, Joseph and Shin Nishio and Gold, \{Michael A.\} and Ke Wang and Kristi McIntyre and Tillmanns, \{Todd D.\} and Blank, \{Stephanie V.\} and Liu, \{Ji Hong\} and Michael McCollum and \{Contreras Mejia\}, Fernando and Tadaaki Nishikawa and Kathryn Pennington and Zoltan Novak and \{De Melou\}, \{Andreia Cristina\} and Jalid Sehouli and Dagmara Klasa-Mazurkiewicz and Christos Papadimitriou and Marta Gil-Martin and Birute Brasiuniene and Conor Donnelly and Xiaochun Liu and Nieuwenhuysen, \{Els Van\}",
year = "2026",
month = apr,
day = "1",
doi = "10.1080/14796694.2026.2638677",
language = "English",
volume = "22",
pages = "1031--1046",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Taylor and Francis Ltd.",
number = "9",
}